NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market on Tuesday that revenues for its fiscal first quarter rose 2 percent year over year, as the company matched the average analysts' estimates on the top and bottom lines. 

For the three months ended Jan. 31, Agilent record $1.03 billion in revenues, equaling the consensus Wall Street estimate. Agilent CFO Didier Hirsch said on a conference call following the release of the firm's financial results that currency effects negatively impacted Q1 2015 revenues by $12 million and EPS by $.01.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.